ProText Mobility, Inc. (TXTM)

ProText Mobility, Inc. (TXTM) — VMCI valuation read

Headline read on TXTM: VMCI of 38/100 versus a Healthcare sector median of 50. The 12-point below-median position is what makes ProText Mobility, Inc. a relative-value laggard in the mid-cap cohort, before any pillar-level review.

Form 4 filings on TXTM: zero in the trailing 30 days. The absence of insider transactions is itself a data point, just a low-information one. The thesis runs on financials and price action until that changes.

**Investor frame.** Three reads on TXTM: value (TXTM trades at 21.0x earnings, 17% above the Healthcare median of 18.0x), quality (ROIC of 19.0% sits 9.0pp above the Healthcare median (10.0%)), and risk (net debt to EBITDA of 2.9x is the rate-sensitivity line to watch). The value read also implies an EV/EBITDA gap of +4.0x against the Healthcare 12.0x baseline.

TXTM rose 3.4% over the trailing 7 days, with a -18.7% read on a 30-day basis.